COF.F
Last
- - (-%)Time
-Previous Close
-
Open
-High
-Low
-
Latest News
ESCMID Global 2026: Zelicapavir demonstrates benefits for high-risk adults with RSV
published on April 23, 2026, 10:18 pm (via Pharmaceutical Technology)
Related Stocks
Disclaimer: The data contained in Super Surge website is not necessarily real-time nor accurate and may differ from the actual market data. Prices, volumes, ratios, charts and indicators are indicative and not appropriate for trading purposes. Super Surge doesn't bear any responsibility for any trading losses you might incur as a result of using this data.